When the rush to new technology may need more consideration: How the American Heart Association may have to resuscitate its policy on defibrillators.
heart failure
Abiomed Announces MIS Cardiac Assist Device at AHA Scientific Sessions
Abiomed announces Symphony™, a new synchronized minimally invasive implantable cardiac assist device.
St. Jude Medical Announces First Use of Renal Denervation Technology
St. Jude Medical, Inc. has announced the first use of the company’s renal denervation catheter and generator system, as part of a feasibility study of the new technology.
SORIN GROUP INVESTS IN ENOPACE BIOMEDICAL, EARLY STAGE COMPANY FOCUSED ON INNOVATIVE SOLUTION FOR HEART FAILURE PATIENTS
Investment will drive development of a unique interventional technology for the largest unmet clinical need in the cardiovascular field
St. Jude Medical Applauds MADIT-CRT Trial
St. Jude Medical, Inc. commends the efforts of investigators in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
New Therapy Found To Prevent Heart Failure
A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator versus patients who received only an implanted cardiac defibrillator.
St. Jude Medical Announces Initial Implant of First-to-Market Connector System in the U.S.
St. Jude Medical, Inc. today announced the first implant of its Current® Plus implantable cardioverter defibrillator (ICD), featuring the SJ4 connector system.
Next-Generation Mechanical Heart Pump Implanted In Heart Patients
Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System.
Covidien Launches Alarm Management System For The Nellcor™ OxiMax™ N-600x™ Pulse Oximeter
Covidien, a leading global supplier of healthcare products, today announced the global launch of its Alarm Management System for the Nellcor™ OxiMax™ N-600x™ pulse oximeter.
500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
The 500th patient was supported with the Berlin Heart EXCOR® Pediatric Ventricular Assist Device (also known as the “Berlin Heart”) since the first implantation of the device in 1990.
Terumo Heart, Inc. Reaches Clinical Milestone with the DuraHeart™ Left Ventricular Assist System
Terumo Heart Inc. today announced reaching a critical milestone in the worldwide expansion of its DuraHeart™ Left-Ventricular Assist System (LVAS) as the 100th patient was treated with the device.
St. Jude Medical Announces European Approval of Its Newest and Most Efficient Heart Failure Devices
St. Jude Medical, Inc. today announced European CE Mark approval of its Promote Accel™ implantable cardiac resynchronization therapy defibrillator (CRT-D).
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices
St. Jude Medical, Inc. today announced U.S. Food and Drug Administration approval of the Promote® Plus cardiac resynchronization therapy defibrillator and Current® Plus implantable cardioverter defibrillators.
Clinical Trial Findings Show Significant Benefits With CVRx® Rheos® System
CVRx announced that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
Cardiac Dimensions®, Inc. Announces Key Personnel Changes
Two important additions to Cardiac Dimension®’s senior management team. Mr. Paul Cornelison recently joined the company as Vice President of Regulatory Affairs and Quality Assurance. In addition, Mr. Nawzer Mehta, Ph.D., has joined the company as Vice President of Clinical Affairs.